Close Menu
  • Indian Festivals 2026
  • Movie & OTT Releases This Week
  • News
  • Entertainment
  • NRI Life
  • Research
  • Advertise with us
Facebook X (Twitter) Instagram YouTube
  • Download Indian Community App
  • Advertise Here
Facebook X (Twitter) Instagram
Indian CommunityIndian Community
Trending
  • Tumbadchi Manjula (2026) Movie Review: A Delightful Marathi Comedy That Wins Hearts With Its Village Charm
  • Mollywood Times (2026) Review: Naslen Shines in a Bold, Bittersweet Love-Hate Letter to Malayalam Cinema
  • Sannidhanam P.O. Movie Review: A Devotional Drama That Speaks From the Heart
  • The Pyramid Scheme Exposes the Fast-Money Dreams Destroying Middle-Class India
  • Brown (2026) Review: Karisma Kapoor Delivers a Career-Defining Performance in This Hauntingly Beautiful Zee5 Crime Drama
  • Gullak Season 5 Review: The Mishras Are Back and More Heartwarming Than Ever
  • Mango Pachcha Review (2026): A Gritty Crime Drama That Hits Close to Home
  • Peddi (2026) Movie Review: Ram Charan’s Career-Best Performance Powers a Stirring Tale of Grit, Identity and Belonging
  • Indian Festivals 2026
  • News
    • National
    • International
    • Entertainment
    • Achievements
    • Scam Alerts
    • Business
    • Health & Medicine
    • Science & Technology
    • Sports
  • Entertainment
  • Latest Movie Releases
    • Latest OTT Releases
  • NRI Life
  • India & Culture
  • Health & Wellness
  • Research
Indian CommunityIndian Community
Home » News » International
International

India and China Urged to Collaborate on Synthetic Drug Threat, Says Former White House Official

Indian Community Editorial TeamBy Indian Community Editorial TeamJune 11, 20262 Mins ReadNo Comments Add us to Google Preferred Sources
India and China Urged to Collaborate on Synthetic Drug Threat, Says Former White House Official
Share
Facebook Twitter LinkedIn Pinterest Email

Former White House drug policy chief Rahul Gupta emphasized the need for India and China to address the rising menace of synthetic drugs and fentanyl trafficking networks together. Gupta highlighted that this issue could potentially become a significant challenge for humanity in the future due to the global reach of synthetic drugs. He stressed the importance of both countries working jointly to combat this escalating threat.

Gupta, who previously led the White House Office of National Drug Control Policy, underscored the global nature of the fentanyl crisis, calling for coordinated efforts from governments, law enforcement agencies, and healthcare systems. He credited the reduction in overdose deaths in the United States to a decrease in the flow of fentanyl precursor chemicals from China to Mexico and the expansion of treatment and overdose prevention programs. Gupta also noted the positive impact of increased access to naloxone and telehealth services in saving lives.

Acknowledging the progress made in addressing the fentanyl crisis, Gupta encouraged ongoing collaboration between the United States and China on this critical issue. He commended the focus on fentanyl in discussions between President Donald Trump and Chinese President Xi Jinping, emphasizing the importance of sustained pressure on China to yield tangible results in saving American lives. However, Gupta cautioned that recent advancements in combating the crisis may be plateauing, underscoring the need for intensified efforts to safeguard every American life at risk.

Regarding India, Gupta recognized the country’s commitment to tackling the drug threat and its readiness to respond effectively. He highlighted the risks faced by India’s chemical industry from illicit drug supply chains and emphasized the importance of strengthening prevention, treatment, and enforcement measures, particularly in regions like Punjab grappling with drug abuse. Gupta stressed the significance of cohesive action between India’s central and state governments to effectively address the crisis, echoing Prime Minister Narendra Modi’s concerns about the drug menace on the global stage.

The fentanyl crisis has emerged as a severe public health challenge in the United States, with synthetic opioids contributing significantly to overdose deaths. Successive administrations have pursued a multifaceted approach involving law enforcement, public health initiatives, and international cooperation to combat this pressing issue.

China Donald Trump Drug Policy drug trafficking fentanyl India Mexico Naloxone Narendra Modi Overdose Deaths Public Health Punjab Rahul Gupta Synthetic Drugs United States White House Xi Jinping
Add us to Google Preferred Sources
Indian Community Editorial Team

The Indian Community Editorial Team curates, verifies, and publishes stories that matter to Indians worldwide. From culture and community to business and innovation, our mission is to spotlight voices, ideas, and events that bring our global community closer together. Have news or a story to share? Submit it to us at [email protected].

Related Posts

India-EU and India-UK Free Trade Agreements: What They Really Mean for Indian Immigration

Canada PR for Indians 2026: 4 Critical Steps to Secure Permanent Residency Through Express Entry

H-1B Visa Interview Appointments for Indians Pushed to 2027: What You Need to Know Now

Add A Comment

CBFC Clears Samantha Ruth Prabhu’s ‘Maa Inti Bangaaram’ for Release

June 11, 2026

Anupam Kher Learns Valuable Lesson on Kindness During Flight

June 11, 2026

Hina Khan Congratulates PM Modi on 12 Years in Office

June 11, 2026

Opendoor Initiates Closure of India Operations, Shifts Roles to US

June 11, 2026
  • Facebook
  • Twitter
  • Pinterest
  • Instagram
About Us
  • About Us
  • Contact Us
  • Terms of Service
Corporate
  • Download Indian Community App
  • Advertise Here
Facebook X (Twitter) Instagram
  • About Us
  • Contact Us
  • Terms of Service
© 2026 Designed by CreativeMerchants.

Type above and press Enter to search. Press Esc to cancel.